| name | ata-post-acth-tumor-gc |
| description | Recommend continuing glucocorticoid replacement until hypothalamic-pituitary-adrenal (HPA) axis recovery after surgical resection of ACTH-secreting pituitary tumors. Use when managing postoperative patients following ACTH-secreting tumor surgery to prevent adrenal insufficiency during HPA axis recovery. |
Continue glucocorticoid replacement until HPA axis recovery post-ACTH-secreting tumor surgery
STEP 1 — Gather Information
Collect postoperative clinical status, surgical pathology confirming ACTH-secreting tumor, timing of surgery, assess for symptoms of adrenal insufficiency (fatigue, hypotension, hyponatremia), obtain morning cortisol level and consider ACTH stimulation test if cortisol equivocal.
→ Proceed to evaluate HPA axis function.
STEP 2 — Rule In / Rule Out
Rule in adrenal insufficiency if morning cortisol <5 µg/dL or subnormal peak cortisol <18.1 µg/dL after standard (250 µg) ACTH stimulation; rule out if morning cortisol ≥15 µg/dL and normal ACTH stim peak.
→ Classify HPA axis recovery status.
STEP 3 — Classify or Stratify
Stratify HPA axis recovery as none (AI present), partial (subnormal response), or full (normal cortisol dynamics).
→ Decide on glucocorticoid management.
STEP 4 — Decide
Continue glucocorticoid replacement (hydrocortisone 15–20 mg daily in divided doses) until full HPA axis recovery is confirmed; taper gradually once normal axis function demonstrated.
→ Provide GC replacement plan.
Clinical Guardrails / Mimics / Pitfalls
Do not stop glucocorticoids prematurely based solely on absence of symptoms; avoid over-replacement leading to iatrogenic Cushingoid features, hyperglycemia, or osteoporosis; consider stress dosing for intercurrent illness even if baseline axis appears recovering.
Concrete Clinical Example
A 45-year-old woman with ACTH-secreting pituitary macroadenoma undergoes transsphenoidal resection; postoperative day 1 she receives hydrocortisone 20 mg daily. Morning cortisol on postoperative day 3 is 2 µg/dL. She continues hydrocortisone 15 mg AM/5 mg PM. At 3 months, morning cortisol is 12 µg/dL with subnormal ACTH stim peak (14 µg/dL); she continues GC replacement. At 6 months, morning cortisol 18 µg/dL and ACTH stim peak 22 µg/dL; glucocorticoids are tapered over 4 weeks and discontinued.
Source: Hormonal Replacement in Hypopituitarism in Adults: An Endocrine Society Clinical Practice Guideline, Endocrine Society, 2016, doi:10.1210/jc.2016-2118
